Search

Search Results
Results 4711 - 4720 of 5053 for Movement Disorder
  • Prezcobix
    Drug - 27 Feb 2026
    Consumer Medicine Information (CMI) about Prezcobix intended for persons living in Australia.
  • Opdualag
    Drug - 19 Feb 2026
    Consumer Medicine Information (CMI) about Opdualag intended for persons living in Australia.
  • Fenac EC
    Drug - 18 Feb 2026
    Consumer Medicine Information (CMI) about Fenac EC intended for persons living in Australia.
  • Remicade
    Drug - 21 Jan 2026
    Consumer Medicine Information (CMI) about Remicade intended for persons living in Australia.
  • Symtuza
    Drug - 19 Jan 2026
    Consumer Medicine Information (CMI) about Symtuza intended for persons living in Australia.
  • Dry January: Key Health Benefits of 30 Days Without Alcohol
    Health - 8 Jan 2026
    Dry January is a global alcohol abstinence challenge associated with metabolic, cardiovascular, and mental health benefits.
  • How Morning Routines Influence Cognitive Performance, Mood, and Circadian Rhythm
    Health - 1 Jan 2026
    How simple, evidence-based morning habits recalibrate the circadian system to sharpen cognition, stabilize mood, and support long-term mental health.
  • DBL Dexamethasone Sodium Phosphate
    Drug - 16 Dec 2025
    Consumer Medicine Information (CMI) about DBL Dexamethasone Sodium Phosphate intended for persons living in Australia.
  • Actrapid, Protaphane, Mixtard 30/70
    Drug - 15 Dec 2025
    Consumer Medicine Information (CMI) about Actrapid, Protaphane, Mixtard 30/70 intended for persons living in Australia.
  • DBL Amikacin Injection
    Drug - 4 Dec 2025
    Consumer Medicine Information (CMI) about DBL Amikacin Injection intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback